We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Dr. Ross is CEO of Miromatrix and has over 18 years of research and product development experience in regenerative medicine and medical devices. He holds a Master’s Degree in Biomedical Engineering and PhD in Cell Biology from the University of Minnesota. He has held various positions at Guidant, Athersys, and SurModics for the development and commercialization of numerous biological based therapies. At Miromatrix, Dr. Ross has lead the commercialized of perfusion decellularization from early research, through GMP manufacturing and FDA 510(k) clearance resulting in the launch of Miromatrix’s first product, MIROMESH, an acellular surgical mesh. He has over 30 published and issued patents along with leading publications in Nature and the Journal of Clinical Investigation.
This speaker's sessions: